MedPath

Efficacy of darvyadi kwath on ekkustha wsr to plaque psoriasis

Phase 2
Conditions
Health Condition 1: L400- Psoriasis vulgarisHealth Condition 2: L400- Psoriasis vulgarisHealth Condition 3: L400- Psoriasis vulgarisHealth Condition 4: L400- Psoriasis vulgaris
Registration Number
CTRI/2023/03/050415
Lead Sponsor
Dr vivek raghuwanshi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

20 year to 60year,

both sexes

Patient having the clinical feature of Ek kushtha-(Plaque Psoriasis),

Patient having chronicity of psoriasis less than 5 year

Patient willing to give consent for trial with firm residential address and contact.

Exclusion Criteria

less than 20 year and more than 60 years.

Patient suffering from diabetes mellitus, cancer, cardiac problems, uncontrolled hypertension,

acquired immunodeficiency syndrome (AIDS), tuberculosis (TB),renal disorder,

Other co-skin disease,

Pregnant women and lactating mother,

Drug or Alcohol Abuse A Known or suspected history of chronic alcohol or drugabuse,

Hypersensitivity to any of the drugs to be used in study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in scaling erythemas and itching <br/ ><br>Timepoint: 45 days
Secondary Outcome Measures
NameTimeMethod
Improvement in scalingTimepoint: 6 month
© Copyright 2025. All Rights Reserved by MedPath